Tardive dyskinesia rates with atypical antipsychotics in older adults

Journal of Clinical Psychiatry

Volumn 65, Issue SUPPL. 9, 2004, Pages 21-24

  Jeste, Dilip V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOZAPINE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; AGE; AGED; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DYSKINESIA; HUMAN; INCIDENCE; MIDDLE AGED; PSYCHOSIS; REVIEW; SCHIZOPHRENIA;

ADULT; AGE FACTORS; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DYSKINESIA, DRUG-INDUCED; HUMANS; INCIDENCE; MIDDLE AGED; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA;

EID: 3042822082     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Jeste DV, Rockwell E, Harris MJ, et al. Conventional vs newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999;7:70-76
2. Kane JM. Prospective study of tardive dyskinesia in the elderly [abstract]. In: Syllabus and Proceedings of the 1999 American Psychiatric Association Annual Meeting; May 15-20, 1999; Washington, DC. Abstract NO32C:79
3. Kane JM, Woerner M, Lieberman J. Tardive dyskinesia: prevalence, incidence and risk factors. J Clin Psychopharmacol 1988;8(suppl 4):52S-56S
4. Caligiuri MP, Lacro JP, Rockwell E, et al. Incidence and risk factors for severe tardive dyskinesia in older patients. Br J Psychiatry 1997;171:148-153
5. Dolder CR, Jeste DV. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biol Psychiatry 2003;53:1142-1145
6. Kahn N, Freeman A, Juncos JL, et al. Clozapine is beneficial for psychosis in Parkinson's disease. Neurology 1991;41:1699-1700
7. Factor SA, Brown D. Clozapine prevents recurrence of psychosis in Parkinson's disease. Mov Disord 1992;7:125-131
8. Safferman AZ, Kane JM, Aronowitz JS, et al. The use of clozapine in neurologic disorders. J Clin Psychiatry 1994;55(9, suppl B):98-101
9. Kane JM, Woerner MG, Pollack S, et al. Does clozapine cause tardive dyskinesia? J Clin Psychiatry 1993;54:327-330
10. Jeste DV, Okamoto A, Napolitano J, et al. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone. Am J Psychiatry 2000;157:1150-1155
11. Jeste DV, Lacro JP, Bailey A, et al. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 1999;47:716-719
12. Beasley CM Jr, Dellva MA, Tamura RN, et al. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol. Br J Psychiatry 1999;174:23-30
13. Kinon B, Jeste DV, Stauffer V, et al. Olanzapine improves tardive dyskinesia in patients with schizophrenia [abstract]. Presented at the 155th annual meeting of the American Psychiatric Association; May 18-23, 2002; Philadelphia, Pa
14. Jeste D, Barak Y, Madhusoodanan S, et al. International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia. Am J Geriatr Psychiatry 2003;11:638-647
15. Sacchetti E, Valsecchi P. Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics a 124-week case report. Int Clin Psychopharmacol 2003;18:357-359
16. McManus DQ, Arvanitis LA, Kowalcyk BB. Quetiapine, a novel antipsychotic: experience in elderly patients. J Clin Psychiatry 1999;60:292-298
17. Jeste D, Glazer W, Morgenstern H, et al. Low incidence of tardive dyskinesia with quetiapine treatment of psychotic disorders in the elderly [poster]. Presented at the 13th annual meeting of the American Association for Geriatric Psychiatry; March 12-15, 2000; Miami, Fla